This is a study using meta-analysis to show that on the average no symptoms in subclinical hypothyroidisim are allievated by T4 therapy. Again, a study showing that MOST patients do not benefit. Categorisation. If most do not benefit, none can, by this assumption. This study blurs out those relatively few who will benefit by subsuming them into the majority who won't. Its like all studies of this kind. If the overall conclusion makes a decision, then all must comply. Patient individuality is ignored yet again. It's these kind of studies that elevate diagnosis of the individual into diagnosis based on the mass.
Clinical ThyroidologyVol. 30, No. 11
Randomized, Controlled Trials Show That Treatment of Subclinical Hypothyroidism Does Not Improve Quality of Life, Cognition, Blood Pressure, or BMI
Tim I.M. Korevaar
Published Online:14 Nov 2018doi.org/10.1089/ct.2018;30....